Skip to content

Abbvie Inc.

Active in EUDAMED
Also registered as AbbVie

United Statesfrom SRN EUDAMED SRN US-MF-000014055

Abbvie Inc. is a medical device manufacturer based in the United States, with 59 devices listed in FDA GUDID, EUDAMED and FDA 510(k) (FDA Class I and II; EU Class IIa and I) and 4 FDA recalls as of 14 Nov 2026.

Devices
59
Registrations
EUDAMED
FDA recalls
4

Registry facts

Counted by deviCERTS from registry records, 14 Nov 2026

Registries
  • FDA GUDID 37
  • EUDAMED 15
  • FDA 510(k) 7

A device listed in two registries counts in both.

Device classes
  • FDA Class I 25
  • FDA Class II 18
  • EU Class IIa 9
  • EU Class I 6
  • FDA Unclassified 1
Sites and related companies
Identifiers
  • EUDAMED SRN US-MF-000014055
  • DUNS 078458370

At a glance

Counted by deviCERTS from registry records

Market reach

European Union
EUDAMED actor
United States
FDA recalls

What Abbvie Inc. makes

The company manufactures reusable personal device holders for medical accessories, including ENFit-compatible connectors for feeding tubes (jejunostomy, nasoenteral, and gastrostomy) and Y-connectors for tube management. It also produces closed-ended one-piece intestinal ostomy bags and subcutaneous self-injection aids. Additionally, the portfolio includes fitted vests for medical device support, such as vest-based infusion systems.

These devices are regulated under Class I and Class II (including Class IIa) classifications, with listings in the EUDAMED database, FDA’s 510(k) premarket notifications, and FDA’s Unique Device Identifier (UDI) registry. The company is based in the United States.

AI-generated from registry data, 26 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue59

Newest first, rows 1-50 of 59

Search and filter all 59 devices
Skip device list

Rows 1-50 of 59

Showing 1-50 of 59

Company details

EUDAMED record synced 7 Nov 2026

EUDAMED SRN
US-MF-000014055
DUNS number
078458370
EUDAMED status
Active
EUDAMED registered name
AbbVie Inc.
Registered address
1 North Waukegan Road, 60064, North Chicago, Illinois, United States
Website
abbvie.com
Phone
+1 800 255-5162
PRRC contact
Andrew Aube(public in EUDAMED)

FDA recalls4

Recalls are matched to the firm by name. FDA recall data as of 1 Nov 2026.

FDA recall records list 4 recalls initiated by ABBVIE INC., the earliest on 2016-11-22 and the most recent on 2017-04-27. By recorded status: 4 terminated. The reasons filed fall into these groups: labeling or instructions for use. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.

Generated automatically from FDA recall records, as a summary of the records listed below. It describes what the records state and is not an assessment of this manufacturer.

Recalls initiated per year

  • 2017 3
  • 2018 0
  • 2019 0
  • 2020 0
  • 2021 0
  • 2022 0
  • 2023 0
  • 2024 0
  • 2025 0
  • 2026 0

1 initiated before 2017

  • 2017

    • 27 Apr 2017 Z-2176-2017 Class II Terminated — Distribution: Nationwide, Albania, Austria, Australia, Belgium, Bulgaria, Canada, Switzerland, Czech Republic, Germany, Denmark,…
      Full distribution text Nationwide, Albania, Austria, Australia, Belgium, Bulgaria, Canada, Switzerland, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, Great Britain, Greece, Croatia, Hungary, Ireland, Italy, Japan, Korea, Luxembourg, Netherlands, Norway, Portugal, Romania, Russia, Saudi Arabia, Sweden, Slovenia, Slovakia, Turkey
      Submission number: K142793
    • 27 Apr 2017 Z-2177-2017 Class II Terminated PEG kits have the potential for one of the following defects: missing components, duplicate components or missing label/Instructions for Use, which includes expiry information. Distribution: Nationwide, Albania, Austria, Australia, Belgium, Bulgaria, Canada, Switzerland, Czech Republic, Germany, Denmark,…
      Full distribution text Nationwide, Albania, Austria, Australia, Belgium, Bulgaria, Canada, Switzerland, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, Great Britain, Greece, Croatia, Hungary, Ireland, Italy, Japan, Korea, Luxembourg, Netherlands, Norway, Portugal, Romania, Russia, Saudi Arabia, Sweden, Slovenia, Slovakia, Turkey
      Submission number: K142793
    • 27 Apr 2017 Z-2178-2017 Class II Terminated PEG kits have the potential for one of the following defects: missing components, duplicate components or missing label/Instructions for Use, which includes expiry information. Distribution: Nationwide, Albania, Austria, Australia, Belgium, Bulgaria, Canada, Switzerland, Czech Republic, Germany, Denmark,…
      Full distribution text Nationwide, Albania, Austria, Australia, Belgium, Bulgaria, Canada, Switzerland, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, Great Britain, Greece, Croatia, Hungary, Ireland, Italy, Japan, Korea, Luxembourg, Netherlands, Norway, Portugal, Romania, Russia, Saudi Arabia, Sweden, Slovenia, Slovakia, Turkey
      Submission number: K142793
  • 2016

    • 22 Nov 2016 Z-0786-2017 Class II Terminated AbbVie is issuing an urgent field correction notification due to an increased number of reports of disconnections of the AbbVie 20FR PEG tube from the Y-connectors. Distribution: U.S. consignees located throughout the country and Puerto Rico. Foreign Consignees: Worldwide. Submission number: K142793

Frequently asked questions

How many devices does ABBVIE INC. have in the registry?

The registry currently lists 59 devices for ABBVIE INC.. Devices recorded under merged duplicate company entries are counted once.

Which registries list ABBVIE INC.'s devices?

Among its 50 most recently registered devices, ABBVIE INC. has devices listed in EUDAMED (10 devices), FDA 510(k) (3 devices) and FDA GUDID (37 devices). A device can be listed in more than one registry, so these counts overlap.

What risk classes do ABBVIE INC.'s devices fall under?

Among its 50 most recently registered devices, the classes recorded for ABBVIE INC.'s devices are Class I, Class IIa and Class II. Each device page shows its own class and authorisation.

Are there FDA recall records for ABBVIE INC.?

FDA recall records list 4 recalls initiated by ABBVIE INC., the most recent initiated on 27 Apr 2017. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.

What are the newest devices from ABBVIE INC. in the registry?

The most recently registered devices listed for ABBVIE INC. include myAbbVieCare Android, myAbbVieCare Patient Portal, myAbbVieCare Apple (iOS) and AbbVie ENFit Y-Connector 15 FR.

Generated automatically from registry data and not verified by a human reviewer.